Insulin capsule study in healthy young men
Part of Hormones & metabolism clinical trials.
This study tests an insulin capsule in healthy young men to see how well it works compared to standard insulin. It may lead to an easier way to take insulin for diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy Chinese men aged 20 to 35
- Body mass index (BMI) between 19 and 24
- Normal blood sugar levels (fasting glucose under 6.1 and 2-hour post-meal under 7.8)
- No significant medical conditions or recent surgeries
- No heavy alcohol, smoking, or drug use
- No use of certain medications or supplements before the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral insulin capsule to see if it can help control blood sugar in people with type 2 diabetes. It might be an option for those who prefer not to use injections.
This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.
This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.